Evolus (EOLS) Short Interest Ratio & Short Volume → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free EOLS Stock Alerts $11.53 -0.03 (-0.26%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Evolus Short Interest DataCurrent Short Volume4,650,000 sharesPrevious Short Volume4,980,000 sharesChange Vs. Previous Month-6.63%Dollar Volume Sold Short$65.10 millionShort Interest Ratio / Days to Cover7.1Last Record DateMarch 31, 2024Outstanding Shares57,940,000 sharesFloat Size47,480,000 sharesShort Percent of Float9.79%Today's Trading Volume348,448 sharesAverage Trading Volume625,641 sharesToday's Volume Vs. Average56% Short Selling Evolus ? Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEOLS Short Interest Over TimeEOLS Days to Cover Over TimeEOLS Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Evolus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00 3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90 2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83 2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77 1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69 1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55 Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53 12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90 11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47 11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91 10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60 10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14 9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14 9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44 8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89 8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20 7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02 7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40 6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27 6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69 5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05 5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32 4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74 4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39 3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46 3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56 2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07 2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37 1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39 1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65 12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51 12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02 11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24 11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54 10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56 10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33 9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05 9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.16 8/31/20222,060,000 shares $19.80 million -3.7%5.7%3.9 $9.61 8/15/20222,140,000 shares $20.24 million +6.5%6.0%4 $9.46The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! EOLS Short Interest - Frequently Asked Questions What is Evolus' current short interest? Short interest is the volume of Evolus shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 4,650,000 shares of EOLS short. 9.79% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest. What is a good short interest ratio for Evolus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 7.0. Learn More on Evolus's short interest ratio. Which institutional investors are shorting Evolus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolus: Citadel Advisors LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Evolus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.79% of Evolus' floating shares are currently sold short. Is Evolus' short interest increasing or decreasing? Evolus saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 4,650,000 shares, a drop of 6.6% from the previous total of 4,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evolus' float size? Evolus currently has issued a total of 57,940,000 shares. Some of Evolus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evolus currently has a public float of 47,480,000 shares. How does Evolus' short interest compare to its competitors? 9.79% of Evolus' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Evolus: Varex Imaging Co. (11.28%), Mind Medicine (MindMed) Inc. (26.84%), Praxis Precision Medicines, Inc. (2.66%), Silk Road Medical, Inc (10.44%), PureTech Health plc (0.02%), Dianthus Therapeutics, Inc. (6.46%), Treace Medical Concepts, Inc. (6.11%), Savara Inc (5.57%), enGene Holdings Inc. (0.17%), OrthoPediatrics Corp. (6.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Evolus stock? Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evolus? A short squeeze for Evolus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further. How often is Evolus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Varex Imaging Short Squeeze Mind Medicine (MindMed) Short Squeeze Praxis Precision Medicines Short Squeeze Silk Road Medical Short Squeeze PureTech Health Short Squeeze Dianthus Therapeutics Short Squeeze Treace Medical Concepts Short Squeeze Savara Short Squeeze enGene Short Squeeze OrthoPediatrics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EOLS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends